Literature DB >> 6117193

The effects of pindolol and prazosin on hand blood flow in patients with cold extremities and on treatment with beta-blockers.

O Ohlsson, S E Lindell.   

Abstract

Hand blood flow and subjective sensitivity to cold were studied in nine hypertensive patients on treatment with beta-blockers. All patients complained of cold extremities. Neither hand blood flow nor sensitivity to cold changed after addition of prazosin, a well known vasodilator to the original beta-blocker. After changing to a beta-blocker with a high degree of intrinsic sympathomimetic activity (pindolol), hand blood flow increased and sensitivity to cold decreased in all patients, except one.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6117193     DOI: 10.1111/j.0954-6820.1981.tb09804.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  7 in total

Review 1.  The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.

Authors:  J D Fitzgerald
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

Review 2.  Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

Authors:  D G Waller
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

3.  Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.

Authors:  J Chambers; M L Ong; F Akhras; G Adam; G Jackson
Journal:  Drugs       Date:  1989       Impact factor: 9.546

4.  Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular disease.

Authors:  E van der Veur; B S ten Berge; A A Wouda; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Peripheral haemodynamic effects of pindolol.

Authors:  O Ohlsson
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 6.  Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 7.  Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.

Authors:  W F Stanaszek; D Kellerman; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.